SCHEMBL6632502

SCHEMBL6632502

CC(=S)c1cccc2c1C(=O)NC2=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ HPGD P15428 2/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ GAA P10253 1/20 0.53
▸ CASP3 P42574 7/20 0.46
▸ GSK3B P49841 2/20 0.43
▸ PARP1 P09874 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CASP2 P42575 2/20 0.38
▸ CASP7 P55210 2/20 0.38
▸ CASP6 P55212 2/20 0.38
▸ CASP8 Q14790 2/20 0.38
▸ LIG1 P18858 1/20 0.38
▸ GSK3A P49840 1/20 0.37
▸ CDK5 Q00535 1/20 0.37
▸ CDK5R1 Q15078 1/20 0.37
▸ CHEK1 O14757 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5128860 0.84 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL3257586 0.81 PARP1 (0.54) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL2065981 0.78 KDM4E (0.53) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL439731 0.78 LIG1 (0.56) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL10339858 0.76 KEAP1 (0.56) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL10967338 0.76 KEAP1 (0.59) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL5127242 0.76 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL11358929 0.76 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL2424940 0.76 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL11612938 0.75 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436249-A2 MUSCARINIC AGONISTS ELI LILLY AND COMPANY (US) 2004-07-14 — — EP disclosed
WO-2003027061-A2 MUSCARINIC AGONISTS ELI LILLY AND COMPANY (US) 2003-04-03 — — WO disclosed
Send feedback